Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • shyam_la
    Member
    • Mar 2012
    • 97

    Query on NonSilent and Silent mutations..

    What is the ratio of non-silent to silent mutations resulting from single nucleotide substitutions that can be expected, if every base is equally mutable and there is no selection pressure?

    Hope the question is clearly framed.

    I am asking so that I can comment on whether my dataset deviates from this hypothetical ratio and hence an idea of how much "Selection" really occurred.
  • BAMseek
    Senior Member
    • Apr 2011
    • 124

    #2
    I wrote some code that basically goes through all 64 possible nucleotide triplets, looks at every possible 1-base substitution (9 possibilities each), and checks if that substitution changes the amino acid.

    The code for this is available at https://gist.github.com/4162316

    I get 576 total substitutions (64*9). 138 are silent and 438 are nonsilent. This would be a ratio of silent:nonsilent = 138:438, which is approx. 1:3.17

    Does that make sense? This was done pre-coffee, so let me know if you find some issues.

    Justin

    Comment

    • HESmith
      Senior Member
      • Oct 2009
      • 512

      #3
      Shyam La,

      You'll also need to factor in the frequencies of the different types of mutations (e.g., transitions vs transversions) produced by your mutagen, as most exhibit significant biases.

      Comment

      • shyam_la
        Member
        • Mar 2012
        • 97

        #4
        Justin,

        That is exactly what I wanted to know; mutate each codon and get the result. Thank you!
        But I'm guessing 1:3.17 is not a biologically meaningful ratio because typically cancers (which is what I am dealing with) have something like 1:2 and they also are subjected to some amount of selection pressure which means we would expect a ratio bigger than 1:3.17 (more non silent than silent).

        HESmith's idea that mutagen biases have to be included is a valid argument, I guess..


        Originally posted by BAMseek View Post
        I wrote some code that basically goes through all 64 possible nucleotide triplets, looks at every possible 1-base substitution (9 possibilities each), and checks if that substitution changes the amino acid.

        The code for this is available at https://gist.github.com/4162316

        I get 576 total substitutions (64*9). 138 are silent and 438 are nonsilent. This would be a ratio of silent:nonsilent = 138:438, which is approx. 1:3.17

        Does that make sense? This was done pre-coffee, so let me know if you find some issues.

        Justin

        Comment

        • BAMseek
          Senior Member
          • Apr 2011
          • 124

          #5
          Yeah, that model might be too simplistic, but I guess it gives a baseline considering all things equal.

          From what I've seen in the literature, the transition to transversion ratio is around 2-2.1 for the entire genome, and around 2.8-3.0 within the exome.

          A more realistic approach might be to take a bunch of normal human exomes and calculate the silent to non silent mutations. Or, instead of trying to find silent/non-silent, maybe calculate the transitions to transversions in your dataset and see if that agrees with the numbers found in literature.

          Justin

          Comment

          • mlodato
            Junior Member
            • Aug 2013
            • 8

            #6
            Perhaps this is useless since the thread is so old, but I have been thinking about this as well and came across this paper:

            PMID:16783027

            which seems to model SNS as well as regional biases to get expected numbers of missense vs nonsense mutations.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM
            • GATTACAT
              Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
              by GATTACAT
              Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
              07-01-2026, 11:43 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 07-13-2026, 10:26 AM
            0 responses
            20 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-09-2026, 10:04 AM
            0 responses
            30 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-08-2026, 10:08 AM
            0 responses
            17 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-07-2026, 11:05 AM
            0 responses
            34 views
            0 reactions
            Last Post SEQadmin2  
            Working...